185 related articles for article (PubMed ID: 26559842)
1. Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein.
Thompson J; Verma D; Li D; Mosbruger T; Swaminathan S
J Virol; 2016 Feb; 90(3):1206-21. PubMed ID: 26559842
[TBL] [Abstract][Full Text] [Related]
2. General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein.
Han Z; Verma D; Hilscher C; Dittmer DP; Swaminathan S
J Virol; 2009 Nov; 83(22):11635-44. PubMed ID: 19726500
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
Nicewonger J; Suck G; Bloch D; Swaminathan S
J Virol; 2004 Sep; 78(17):9412-22. PubMed ID: 15308735
[TBL] [Abstract][Full Text] [Related]
4. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
5. Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs.
Verma D; Kim EA; Swaminathan S
J Virol; 2013 Oct; 87(19):10742-51. PubMed ID: 23903829
[TBL] [Abstract][Full Text] [Related]
6. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
Fu W; Verma D; Burton A; Swaminathan S
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S
J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
Verma D; Thompson J; Swaminathan S
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA.
Ruvolo V; Gupta AK; Swaminathan S
J Virol; 2001 Jul; 75(13):6033-41. PubMed ID: 11390605
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
Verma D; Church TM; Swaminathan S
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production.
Ruvolo V; Sun L; Howard K; Sung S; Delecluse HJ; Hammerschmidt W; Swaminathan S
J Virol; 2004 Jan; 78(1):340-52. PubMed ID: 14671116
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
Fachko DN; Chen Y; Skalsky RL
J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
[TBL] [Abstract][Full Text] [Related]
13. Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.
Verma D; Ling C; Johannsen E; Nagaraja T; Swaminathan S
J Virol; 2009 Aug; 83(16):8041-50. PubMed ID: 19515786
[TBL] [Abstract][Full Text] [Related]
14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
15. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
16. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
17. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.
Gruffat H; Batisse J; Pich D; Neuhierl B; Manet E; Hammerschmidt W; Sergeant A
J Virol; 2002 Oct; 76(19):9635-44. PubMed ID: 12208942
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.
Ruvolo V; Wang E; Boyle S; Swaminathan S
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8852-7. PubMed ID: 9671768
[TBL] [Abstract][Full Text] [Related]
20. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]